PS-388023

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NamePS-388023

Drug Alias Nameangiogenesis inhibitors (Pharmacopeia/Allergan)dual integrin avb3/avb5 inhibitors (Pharmacopeia)angiogenesis inhibitors (Pharmacopeia)dual integrin alpha-5/beta-3 + alpha-5/beta-5 inhibitors (Pharmacopeia)PS-780035 +[7]

ClassificationSmall molecules

Mechanisms of ActionAngiogenesis inhibitorsIntegrin alpha-V/beta-3 antagonists

TargetsIntegrin alpha-V/beta-3

Therapy Area/IndicationsInflammationEye DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPharmacopeia Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPharmacopeia Llc Allergan Inc

Active IndicationsN/A

Inactive IndicationsInflammationEye DiseasesNeoplasms

Other Information

ATC CodeN/A